All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain.
Research output: Book/Report › Commissioned report
Standard Standard
All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. / Hughes, D.; Hughes, D.A.; All Wales Strategy Group., [No Value].
2008 ed. Unknown, 2008.
2008 ed. Unknown, 2008.
Research output: Book/Report › Commissioned report
HarvardHarvard
Hughes, D, Hughes, DA & All Wales Strategy Group., NV 2008, All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. 2008 edn, Unknown.
APA
Hughes, D., Hughes, D. A., & All Wales Strategy Group., N. V. (2008). All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. (2008 ed.) Unknown.
CBE
Hughes D, Hughes DA, All Wales Strategy Group. NV 2008. All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. 2008 ed. Unknown.
MLA
Hughes, D., D.A. Hughes and [No Value] All Wales Strategy Group. All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. 2008 udg. Unknown. 2008.
VancouverVancouver
Hughes D, Hughes DA, All Wales Strategy Group. NV. All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. 2008 ed. Unknown, 2008.
Author
RIS
TY - BOOK
T1 - All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain.
AU - Hughes, D.
AU - Hughes, D.A.
AU - All Wales Strategy Group., [No Value]
PY - 2008/1/1
Y1 - 2008/1/1
UR - http://www.wales.nhs.uk/sites3/Documents/371/ziconotide%20Prialt%20FAR.pdf
M3 - Commissioned report
BT - All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain.
PB - Unknown
ER -